$3.04
-0.16[-5.00%]
Last update: 4:00PM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
$3.00
-0.0400[-1.32%]
| Open3.200 | Close3.040 |
| Vol / Avg.2.903M / 4.187M | Mkt Cap325.136M |
| Day Range3.040 - 3.230 | 52 Wk Range2.780 - 8.580 |
bluebird bio Stock (NASDAQ:BLUE), Key Statistics
bluebird bio Stock (NASDAQ: BLUE) analysis, key statistics.
Valuation Measures
Enterprise Value
386.7M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
32.2
Price / Book (mrq)
1.18
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-26.88%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
2.7
Tangible Book value per share
2.6
Total Liabilities (Quarterly)
374.4M
Total Assets
663.4M
Total Liabilities
374.4M
Profitability
Net income Growth
- -
Gross Margin
-38.81%
Net Margin
-1058.17%
EBIT Margin
-1237.98%
EBITDA Margin
-1223.9%
Operating Margin
-1237.98%
bluebird bio Stock (NASDAQ:BLUE), Key Statistics
bluebird bio Stock (NASDAQ: BLUE) analysis, key statistics.
Valuation Measures
Enterprise Value
386.7M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
32.2
Price / Book (mrq)
1.18
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-26.88%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
2.7
Tangible Book value per share
2.6
Total Liabilities (Quarterly)
374.4M
Total Assets
663.4M
Total Liabilities
374.4M
Profitability
Net income Growth
- -
Gross Margin
-38.81%
Net Margin
-1058.17%
EBIT Margin
-1237.98%
EBITDA Margin
-1223.9%
Operating Margin
-1237.98%
bluebird bio Stock (NASDAQ:BLUE), Key Statistics
bluebird bio Stock (NASDAQ: BLUE) analysis, key statistics.
Valuation Measures
Enterprise Value
386.7M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
32.2
Price / Book (mrq)
1.18
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-26.88%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
2.7
Tangible Book value per share
2.6
Total Liabilities (Quarterly)
374.4M
Total Assets
663.4M
Total Liabilities
374.4M
Profitability
Net income Growth
- -
Gross Margin
-38.81%
Net Margin
-1058.17%
EBIT Margin
-1237.98%
EBITDA Margin
-1223.9%
Operating Margin
-1237.98%
bluebird bio Stock (NASDAQ:BLUE), Key Statistics
bluebird bio Stock (NASDAQ: BLUE) analysis, key statistics.
Valuation Measures
Enterprise Value
386.7M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
32.2
Price / Book (mrq)
1.18
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-26.88%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
2.7
Tangible Book value per share
2.6
Total Liabilities (Quarterly)
374.4M
Total Assets
663.4M
Total Liabilities
374.4M
Profitability
Net income Growth
- -
Gross Margin
-38.81%
Net Margin
-1058.17%
EBIT Margin
-1237.98%
EBITDA Margin
-1223.9%
Operating Margin
-1237.98%
bluebird bio Stock (NASDAQ:BLUE), Key Statistics
bluebird bio Stock (NASDAQ: BLUE) analysis, key statistics.
Valuation Measures
Enterprise Value
386.7M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
32.2
Price / Book (mrq)
1.18
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-26.88%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
2.7
Tangible Book value per share
2.6
Total Liabilities (Quarterly)
374.4M
Total Assets
663.4M
Total Liabilities
374.4M
Profitability
Net income Growth
- -
Gross Margin
-38.81%
Net Margin
-1058.17%
EBIT Margin
-1237.98%
EBITDA Margin
-1223.9%
Operating Margin
-1237.98%
bluebird bio Stock (NASDAQ:BLUE), Key Statistics
bluebird bio Stock (NASDAQ: BLUE) analysis, key statistics.
Valuation Measures
Enterprise Value
386.7M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
32.2
Price / Book (mrq)
1.18
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-26.88%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
2.7
Tangible Book value per share
2.6
Total Liabilities (Quarterly)
374.4M
Total Assets
663.4M
Total Liabilities
374.4M
Profitability
Net income Growth
- -
Gross Margin
-38.81%
Net Margin
-1058.17%
EBIT Margin
-1237.98%
EBITDA Margin
-1223.9%
Operating Margin
-1237.98%
bluebird bio Stock (NASDAQ:BLUE), Key Statistics
bluebird bio Stock (NASDAQ: BLUE) analysis, key statistics.
Valuation Measures
Enterprise Value
386.7M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
32.2
Price / Book (mrq)
1.18
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-26.88%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
2.7
Tangible Book value per share
2.6
Total Liabilities (Quarterly)
374.4M
Total Assets
663.4M
Total Liabilities
374.4M
Profitability
Net income Growth
- -
Gross Margin
-38.81%
Net Margin
-1058.17%
EBIT Margin
-1237.98%
EBITDA Margin
-1223.9%
Operating Margin
-1237.98%
bluebird bio Stock (NASDAQ:BLUE), Key Statistics
bluebird bio Stock (NASDAQ: BLUE) analysis, key statistics.
Valuation Measures
Enterprise Value
386.7M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
32.2
Price / Book (mrq)
1.18
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-26.88%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
2.7
Tangible Book value per share
2.6
Total Liabilities (Quarterly)
374.4M
Total Assets
663.4M
Total Liabilities
374.4M
Profitability
Net income Growth
- -
Gross Margin
-38.81%
Net Margin
-1058.17%
EBIT Margin
-1237.98%
EBITDA Margin
-1223.9%
Operating Margin
-1237.98%
bluebird bio Stock (NASDAQ:BLUE), Key Statistics
bluebird bio Stock (NASDAQ: BLUE) analysis, key statistics.
Valuation Measures
Enterprise Value
386.7M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
32.2
Price / Book (mrq)
1.18
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-26.88%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
2.7
Tangible Book value per share
2.6
Total Liabilities (Quarterly)
374.4M
Total Assets
663.4M
Total Liabilities
374.4M
Profitability
Net income Growth
- -
Gross Margin
-38.81%
Net Margin
-1058.17%
EBIT Margin
-1237.98%
EBITDA Margin
-1223.9%
Operating Margin
-1237.98%